A widely used epilepsy drug is in critically short supply across Canada, leaving patients and their family members scrambling for alternatives. The shortage of valproic acid, also known by the brand name Epival, began in December but has escalated ...
By clicking “submit,” you agree to receive emails from Ability Today and accept our web terms of use and privacy and cookie policy.